RE: Sales15 May 2026 06:45
Risk from black market and bad publicity but MPAL pharmaceutical/clinical services should be seen as the more appropriate choice for those seeking to use weight loss injections, if not the market leading regulated service.
Only one string to MPALs bow though.
MedPal AI announced that its subsidiary was approved as an authorised purchaser of Eli Lilly medicines in the UK, including the GLP-1 weight-loss injection Mounjaro (tirzepatide).
They also already supply Wegovy and integrated GLP-1 assessment pathways into the MedPal app and clinic platform.
AI-driven screening and triage integrated into the MedPal wellness app.
Robotic dispensing and nationwide fulfilment from the Norfolk distribution centre
Expansion into GLP-1 blood testing and monitoring for users of Mounjaro and Wegovy.
“Novo Nordisk is the pharmaceutical company behind the GLP-1 semaglutide - which is used in Wegovy and Ozempic. However, its stronghold on this particular GLP-1 has come to an end in India and Canada and will soon lapse in China, Brazil, and Turkey.
This will leave other companies free to pinch the recipe and manufacture generic versions of the drug which have not been approved by UK regulators.
Experts at the Health and Social Care Committee voiced concerns on Wednesday that the drug will be manufactured on a wide scale and that access to illicit versions will increase.
Since the patent expired on Friday in India, some seven pharmaceuticals firms have already announced plans to create versions of the drug at much lower prices than Novo Nordisk.
Indian company Eris Life Sciences will sell a multi-dose vial for just £10.33, while Glenmark unveiled a product costing between £10.39 and £14.08 per month.
Other brands launched oral tablets alongside jabs and Zydus Lifesciences released a range of reusable pens for £17.60.
There is already a black market for skinny jabs, with many counterfeit or unlicensed products already circulating across the UK
At a Health and Social Care Committee meeting on Wednesday, Andy Morling for the Medicines and Healthcare Regulatory Agency said 81,000 unlicensed doses of the weight loss jab had been seized in the last three years.
Whilst the products are mostly genuine, it does not make it safe as many of these products will have not adhered to UK manufacturing guidelines.
“The sterility is questionable, the dosage is questionable,” said Mr Morling.
Dr Nadia Ahmad, doctor and medical director of The Weight Care Clinic, told The Standard: “People think they’re getting ozempic or Wegovy but you don’t know what’s inside. Doses can be wrong, products can be contaminated, or completely fake.
Clinically, I’ve seen patients become very unwell. People can suffer from dehydration, electrolyte imbalance, pancreatitis and in worst cases, this can be fatal.”
Those looking to obtain these medications should ensure that they are prescribed by a pharmacy or properly regulated service.”
Sign In
Follow the stocks
